Immune suppressive therapy
Showing 26 - 50 of >10,000
Immune Checkpoint Inhibitor Monotherapy or Combined With
Not yet recruiting
- Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
- Immune checkpoint inhibitor
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
Jan 30, 2023
Last Period Not Earlier Than 6 Months Ago Trial in Moscow (oral menopausal hormone therapy, transdermal menopausal hormone
Active, not recruiting
- Last Period Not Earlier Than 6 Months Ago
- oral menopausal hormone therapy
- transdermal menopausal hormone therapy
-
Moscow, Russian FederationFederal State Budget Institution Research Center for Obstetrics,
Jan 9, 2023
Actinic Keratosis, Photodynamic Therapy Trial in Fairborn (Celecoxib 200mg, Placebo)
Recruiting
- Actinic Keratosis
- Photodynamic Therapy
- Celecoxib 200mg
- Placebo
-
Fairborn, OhioWright State Physicians
Jan 9, 2023
Immune-related Adverse Events Refractory to Standard Therapy and
Recruiting
- Immune-related Adverse Event
- Extracorporeal photopheresis
- Other immunosuppressive or immunomodulatory drugs
-
Munich, GermanyLMU Klinikum Hauttumorzentrum
Jan 17, 2023
Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,
Completed
- Gastrointestinal Tumor
- Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
- tislelizumab (BeiGene, China) combined with PD-1 inhibitor
-
Hangzhou, ChinaZhejiang Hospital
Sep 1, 2023
Immune-related Colitis, Colitis Trial in Minneapolis (RMT, Placebo)
Not yet recruiting
- Immune-related Colitis
- Colitis
- RMT
- Placebo
-
Minneapolis, MinnesotaUniversity of Minnesota
Feb 4, 2023
Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Durvalumab
- Rintatolimod
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 23, 2023
Adjuvant Immune Checkpoint Inhibitors in Postoperative
Recruiting
- Hepatocellular Carcinoma
- Immune Checkpoint Inhibitors Based Adjuvant therapy
-
Nanning, Guangxi, ChinaJian-Hong Zhong
Jan 18, 2023
Pediatric Cancer Trial in Charlotte (Vaccine)
Recruiting
- Pediatric Cancer
- Vaccine
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 27, 2023
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
Determine Pro-Inflammatory Cytokine Kinetics During Immune
Not yet recruiting
- Non Small Cell Lung Cancer
- Melanoma
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jan 30, 2023
Sepsis, Severe Trial in Germany (ARTICE)
Recruiting
- Sepsis, Severe
- ARTICE
-
Braunschweig, Germany
- +3 more
Jul 29, 2022
Neoadjuvant Therapy in Rectal Cancer
Recruiting
- Rectal Cancer
- Immune checkpoint measure
-
Istanbul, TurkeyIstanbul Training and Research Hospital
Jul 9, 2022
Healthcare Resource Utilization and Costs of Immune Checkpoint
Completed
- Melanoma
-
East Hanover, New JerseyNovartis
May 12, 2023
Immune Function and PD-1 Antibody Therapy Efficacy Predictors on
Recruiting
- Secondary Hemophagocytic Lymphohistiocytosis
- Chronic Active Epstein-Barr Virus Infection
- No intervention
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 2, 2023
Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Stereotactic body radiotherapy (SBRT)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Sep 15, 2023
Immune Reconstitution to CMV After HSCT: Impact of Clinical
Enrolling by invitation
- CMV Infection
- Hematopoietic Stem Cell Transplantation
-
Beijing, Beijing, China
- +1 more
Jan 5, 2023
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gemtuzumab Ozogamicin
-
Valhalla, New YorkNew York Medical College
Sep 26, 2022
Melanoma Trial in Durham (Tetanus Diptheria Vaccine, Polio Boost Immunization)
Recruiting
- Melanoma
- Tetanus Diptheria Vaccine
- Polio Boost Immunization
-
Durham, North CarolinaDuke University Medical Center
Sep 8, 2022
HIV-infected Patients Switching to Long Acting Dual Therapy
Not yet recruiting
- HIV-1-infection
- (no location specified)
Jun 24, 2022
Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)
Recruiting
- Immune-Mediated Colitis
- Tofacitinib 10 mg
-
Montreal, Quebec, CanadaSir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
May 11, 2022
Lentiviral-based Gene-edited Immune Cell Therapy
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- +4 more
- Pell's lentiviral-based gene-edited immune cell therapy
-
Kaohsiung, Taiwan
- +2 more
Oct 25, 2022
Cancer, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors Trial in Zurich (Fecal Microbiota Transplantation (FMT))
Recruiting
- Cancer
- +2 more
- Fecal Microbiota Transplantation (FMT)
-
Zurich, SwitzerlandUniversity of Zurich, University Hospital Zurich
Jun 14, 2022
Metastatic Melanoma Trial in Stockholm (Precision Radiation (SBRT))
Recruiting
- Metastatic Melanoma
- Precision Radiation (SBRT)
-
Stockholm, SwedenDivision of Head-Neck, Lung and Skin cancers, Theme Cancer, Karo
Aug 16, 2022